We are live on ! Find out more
CCM

Callodine Capital Management Portfolio holdings

AUM $1.43B
1-Year Est. Return 8.74%
This Fund
S&P 500
This Quarter Est. Return
-12.03%
1 Year Est. Return
+8.74%
3 Year Est. Return
+43.6%
5 Year Est. Return
+40.63%
10 Year Est. Return
–
AUM
$337M
AUM Growth
+$26M
Cap. Flow
+$70.1M
Cap. Flow %
20.76%
Top 10 Hldgs %
41.52%
Holding
54
New
11
Increased
24
Reduced
11
Closed
4

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$12.4M
2
BBDC icon
Barings BDC
BBDC
+$9.14M
3
SNY icon
Sanofi
SNY
+$8.86M
4
BXSL icon
Blackstone Secured Lending
BXSL
+$8.47M
5
KKR icon
KKR & Co
KKR
+$8.13M

Top Sells

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$13.9M
2
LPLA icon
LPL Financial
LPLA
+$4.57M
3
MO icon
Altria Group
MO
+$4.27M
4
TMUS icon
T-Mobile US
TMUS
+$3.91M
5
CEG icon
Constellation Energy
CEG
+$3.65M

Sector Composition

Rank Sector Weight
1 Financials 48.54%
2 Healthcare 11.66%
3 Real Estate 10.11%
4 Consumer Discretionary 9.13%
5 Communication Services 5.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BBDC icon
1
Barings BDC
BBDC
$862M
$18.5M 5.48%
1,987,689
+900,189
+83% +$9.14M
RDN icon
2
Radian Group
RDN
$5.14B
$17.7M 5.24%
900,000
+270,000
+43% +$5.67M
TSLX icon
3
Sixth Street Specialty
TSLX
$1.59B
$16.2M 4.81%
877,016
+256,516
+41% +$5.43M
MRK icon
4
Merck
MRK
$324B
$14.1M 4.19%
155,000
+140,000
+933% +$12.4M
ARES icon
5
Ares Management
ARES
$28.5B
$13.4M 3.96%
235,000
+111,500
+90% +$7.71M
EQH icon
6
Equitable Holdings
EQH
$13.1B
$12.7M 3.78%
488,930
+27,680
+6% +$802K
ADC icon
7
Agree Realty
ADC
$9.68B
$12.3M 3.63%
170,000
+21,074
+14% +$1.46M
VST icon
8
Vistra
VST
$55.1B
$12M 3.56%
525,043
+40,043
+8% +$990K
KKR icon
9
KKR & Co
KKR
$89.2B
$11.8M 3.5%
255,000
+155,000
+155% +$8.13M
BXSL icon
10
Blackstone Secured Lending
BXSL
$5.41B
$11.4M 3.37%
481,643
+326,639
+211% +$8.47M
VTRS icon
11
Viatris
VTRS
$20.1B
$11.3M 3.34%
1,076,273
+101,273
+10% +$1.11M
PNNT
12
Pennant Park Investment Corp
PNNT
$215M
$11.2M 3.32%
1,813,680
+18,480
+1% +$132K
VZ icon
13
Verizon
VZ
$194B
$11M 3.27%
217,500
-65,000
-23% -$3.29M
GLPI icon
14
Gaming and Leisure Properties
GLPI
$12.8B
$9.72M 2.88%
211,989
+8,414
+4% +$385K
SPB icon
15
Spectrum Brands
SPB
$2.04B
$9.64M 2.86%
117,500
+26,801
+30% +$2.3M
MPT
16
Medical Properties Trust
MPT
$2.89B
$9.59M 2.84%
628,206
+73,206
+13% +$1.32M
TRIN icon
17
Trinity Capital
TRIN
$1.55B
$9.11M 2.7%
629,502
+78,275
+14% +$1.28M
VVV icon
18
Valvoline
VVV
$4.97B
$8.79M 2.61%
305,000
+102,705
+51% +$3.15M
OWL icon
19
Blue Owl Capital
OWL
$6.39B
$8.49M 2.52%
846,918
+110,668
+15% +$1.33M
SNY icon
20
Sanofi
SNY
$104B
$8.35M 2.47%
+166,935
New +$8.86M
FSK icon
21
FS KKR Capital
FSK
$2.98B
$7.77M 2.3%
400,000
+75,000
+23% +$1.59M
SAH icon
22
Sonic Automotive
SAH
$3.15B
$7.69M 2.28%
210,000
-14,644
-7% -$629K
MO icon
23
Altria Group
MO
$122B
$6.27M 1.86%
150,000
-82,500
-35% -$4.27M
TMUS icon
24
T-Mobile US
TMUS
$193B
$6.05M 1.79%
45,000
-30,000
-40% -$3.91M
BMY icon
25
Bristol-Myers Squibb
BMY
$127B
$5.58M 1.65%
72,500
-182,500
-72% -$13.9M
1
2 3

Similar funds

TS
Triglav Skladi Ljubljana, Slovenia $1.43B AUM 39.24% 1-Year Est. Return
SMA
Sage Mountain Advisors Atlanta, Georgia $1.43B AUM 16.47% 1-Year Est. Return
SCA
Stonebridge Capital Advisors St Paul, Minnesota $1.43B AUM 21.98% 1-Year Est. Return
SC
Styrax Capital New York $1.43B AUM 50.63% 1-Year Est. Return
ADL
Asset Dedication LLC San Francisco, California $1.43B AUM 22.07% 1-Year Est. Return
KPF
K2 Principal Fund Toronto, Ontario, Canada $1.43B AUM 29.56% 1-Year Est. Return
KGI
Kopernik Global Investors Tampa, Florida $1.43B AUM 63.57% 1-Year Est. Return
WIM
Weitz Investment Management Omaha, Nebraska $1.43B AUM 0.51% 1-Year Est. Return

Callodine Capital Management's Q2 2022 Portfolio in Review

As of Q2 2022, Callodine Capital Management held 54 positions worth $337M, up 8.3% from $311M the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Callodine Capital Management deployed $70.1M of net new capital in Q2 2022, opening 11 new positions and adding to 24 existing holdings. Its largest new stake was Sanofi: 166,935 shares worth $8.35M.

By sector, the portfolio is most concentrated in Financials at 49% of assets, up from 45% a quarter earlier, followed by Healthcare and Real Estate.

On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $13.9M trimmed.

  • Callodine Capital Management's largest Q2 2022 buy was Sanofi: 166,935 shares worth $8.35M.
  • Callodine Capital Management added most to Merck in Q2 2022, an estimated $12.4M increase.
  • Callodine Capital Management's biggest Q2 2022 reduction was Bristol-Myers Squibb, cutting an estimated $13.9M.
  • Callodine Capital Management fully exited LPL Financial in Q2 2022, selling an estimated $4.57M.
  • Callodine Capital Management's ten largest holdings make up 42% of its $337M portfolio in Q2 2022.
  • Callodine Capital Management opened 11 new positions and closed 4 in Q2 2022.
  • Callodine Capital Management's portfolio value rose 8.3% quarter-over-quarter to $337M.

Based on Callodine Capital Management's 13F filing for Q2 2022, filed 12 Aug 2022.